A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Bismuth, Random Urine with Creatinine
Test Code6060
CPT Codes
83018, 82570
Includes
Creatinine
Preferred Specimen
7 mL random urine collected in an acid-washed or metal-free container
Patient Preparation
Avoid taking mineral supplements and bismuth preparations such as Pepto-Bismol for at least 1 week prior to collection.
Minimum Volume
3 mL
Instructions
Collect urine in an acid-washed or metal-free plastic container.
Note: Tests performed on a specimen submitted in a non-trace element tube or non acid-washed/non metal-free container may not accurately reflect the patient's level. If a non-trace element tube/container is received, it will be accepted for testing. However, elevated results shall be reported with a message that a re-submission with a trace element tube/container is recommended.
Note: Tests performed on a specimen submitted in a non-trace element tube or non acid-washed/non metal-free container may not accurately reflect the patient's level. If a non-trace element tube/container is received, it will be accepted for testing. However, elevated results shall be reported with a message that a re-submission with a trace element tube/container is recommended.
Transport Container
Acid-washed plastic urine container
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 5 days
Frozen: 14 days
Refrigerated: 5 days
Frozen: 14 days
Methodology
Inductively Coupled Plasma/Mass Spectrometry (ICP/MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
This test code is for non-New York patient testing. For New York patient testing, see test code 13722.
Reference Range
Bismuth, Random Urine
Creatinine, Random Urine
Non-exposed Adult | ≤7.4 mcg/g creat |
Creatinine, Random Urine
≤6 Months | 2-28 mg/dL | |
7-11 Months | 2-31 mg/dL | |
1-2 Years | 2-110 mg/dL | |
3-8 Years | 2-130 mg/dL | |
9-12 Years | 2-160 mg/dL | |
>12 Years Male | 20-320 mg/dL | |
>12 Years Female | 20-275 mg/dL |
Clinical Significance
Excessive use of Bismuth containing medications may cause renal damage and other adverse effects.
Performing Laboratory
med fusion |
2501 South State Hwy 121, Suite 1100 |
Lewisville, TX 75067-8188 |